These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1838876)

  • 1. Metoclopramide test in women with PCO syndrome after ovarian wedge resection.
    Vĕtr M; Talas M; Sobek A; Charamza J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():257-64. PubMed ID: 1838876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with bromocriptine in normoprolactinemic anovulatory women.
    Suginami H; Hamada K; Yano K; Kuroda G; Matsuura S
    J Clin Endocrinol Metab; 1986 May; 62(5):899-903. PubMed ID: 3958126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine].
    Suginami H; Ito T; Hamada K; Yano K; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):728-34. PubMed ID: 3722953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine and metoclopramide in polycystic ovary syndrome.
    Barnes RB; Mileikowsky GN; Cha KY; Spencer CA; Lobo RA
    J Clin Endocrinol Metab; 1986 Aug; 63(2):506-9. PubMed ID: 3722335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transitory hyperprolactinemia on in vitro fertilization of human oocytes.
    Mendes MC; Ferriani RA; Sala MM; Moura MD; Carrara HH; de Sá MF
    J Reprod Med; 2001 May; 46(5):444-50. PubMed ID: 11396370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the metoclopramide test in diagnosis of hormonal causes of female sterility].
    Matt O; Gerhard I; Runnebaum B
    Zentralbl Gynakol; 1992; 114(11):539-46. PubMed ID: 1481585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered functional status of the hypothalamic dopaminergic tone in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a pilot study.
    Parra A; Ramírez-Peredo J; Hidalgo R; Morales-Toquero A; Velásquez-Ramírez G; Ruiz-Argüelles A; Ruiz-Argüelles GJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):566-72. PubMed ID: 16635792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum prolactin during oral metoclopramide in normal nulliparous women].
    Ramírez A; Espinosa de los Monteros A; Coria I; Hortencia Valencia Q; Parra A
    Ginecol Obstet Mex; 1993 Apr; 61():96-101. PubMed ID: 8406122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactin stimulation using the metoclopramide test in females taking oral contraceptives].
    Carol W; Lauterbach H; Klinger G; Unger A; Michels W
    Zentralbl Gynakol; 1988; 110(23):1515-21. PubMed ID: 3149100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Luteal insufficiency as a prolactin-related disorder of the menstrual cycle].
    Bohnet HG
    Fortschr Med; 1980 Nov; 98(41):1618-23. PubMed ID: 6781997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia and disorders of the menstrual cycle].
    Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
    Med Pregl; 1999; 52(3-5):156-61. PubMed ID: 10518402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.